The global single-use bioprocessing market size reached US$ 16.1 Billion in 2023. Looking forward, the market is projected to reach US$ 64.5 Billion by 2032, exhibiting a growth rate (CAGR) of 16.67% during 2023-2032. The growing prevalence of chronic diseases, increasing technological advancements, and rising number of drug approvals and biologics represent some of the key factors driving the market.
Single-use bioprocessing technology is designed for filtration, storage, cell culture, mixing, and purification of biopharmaceutical products for one-time use. It is cost-effective, timesaving, and provides flexibility and hassle-free disposal. It assists in increasing productivity by eliminating complex steps and reduces the risks of cross-contamination among individuals as compared to traditional bioprocessing.
Besides this, it is beneficial in reducing energy, media consumption, and carbon footprint and providing a sustainable manufacturing process as compared to steel. It is utilized for the effective production of vaccines, plant cell cultivation, and monoclonal antibodies. As it also reduces the time of staff members for set-up, validation, and documentation, the demand for single-use bioprocessing technology is increasing across the globe.
Besides this, various benefits offered by single-use bioprocessing systems, such as lower labor, material, and investment costs, are propelling the growth of the market. In addition to this, the emergence of various technological advancements, such as artificial intelligence (AI), machine learning (ML), and big data solutions in single-use bioprocessing for predicting errors and improving accuracy, is bolstering the growth of the market. Moreover, the growing utilization of single-use bioprocessing in media preparation and shipping of biologics while manufacturing pharmaceuticals is offering a favorable market outlook.
In line with this, the rising adoption of single-use bioprocessing, as it reduces the amount of carbon dioxide (CO2) compared to traditional bioprocessing, is impelling the growth of the market. Furthermore, the increasing employment of single-use bioprocessing due to the improving healthcare facilities across the globe is contributing to the growth of the market.
Some of the companies covered include Applikon Biotechnology, Boehringer Ingelheim, Cesco Bioengineering Company, Corning Inc., Danaher Corporation, Entegris, Eppendorf AG, Finesse Solutions Inc., GE Healthcare, Infors, Merck Millipore, Rentschler Biotechnologie, Sartorius Stedim Biotech, Thermo Fisher Scientific Inc., 3M Company, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
2. What is the expected growth rate of the global single-use bioprocessing market during 2024-2032?
3. What are the key factors driving the global single-use bioprocessing market?
4. What has been the impact of COVID-19 on the global single-use bioprocessing market?
5. What is the breakup of the global single-use bioprocessing market based on the product type?
6. What is the breakup of the global single-use bioprocessing market based on the application?
7. What is the breakup of the global single-use bioprocessing market based on the end-use?
8. What is the breakup of the global single-use bioprocessing market based on the end-user?
9. What are the key regions in the global single-use bioprocessing market?
10. Who are the key players/companies in the global single-use bioprocessing market?
Single-use bioprocessing technology is designed for filtration, storage, cell culture, mixing, and purification of biopharmaceutical products for one-time use. It is cost-effective, timesaving, and provides flexibility and hassle-free disposal. It assists in increasing productivity by eliminating complex steps and reduces the risks of cross-contamination among individuals as compared to traditional bioprocessing.
Besides this, it is beneficial in reducing energy, media consumption, and carbon footprint and providing a sustainable manufacturing process as compared to steel. It is utilized for the effective production of vaccines, plant cell cultivation, and monoclonal antibodies. As it also reduces the time of staff members for set-up, validation, and documentation, the demand for single-use bioprocessing technology is increasing across the globe.
Single-Use Bioprocessing Market Trends
Presently, the rising prevalence of chronic diseases, such as diabetes, asthma, arthritis, cancer, hypertension, heart attack, stroke, and chronic obstructive pulmonary disease (COPD), among the masses across the globe represents one of the key factors supporting the growth of the market. Apart from this, the growing demand for single-use bioprocessing due to the increasing number of drug approvals and biologics around the world is positively influencing the market. Additionally, rising preferences of products manufactured from high-grade polymer materials and plastic composites, as they offer enhanced integral strength, is offering lucrative growth opportunities to industry investors.Besides this, various benefits offered by single-use bioprocessing systems, such as lower labor, material, and investment costs, are propelling the growth of the market. In addition to this, the emergence of various technological advancements, such as artificial intelligence (AI), machine learning (ML), and big data solutions in single-use bioprocessing for predicting errors and improving accuracy, is bolstering the growth of the market. Moreover, the growing utilization of single-use bioprocessing in media preparation and shipping of biologics while manufacturing pharmaceuticals is offering a favorable market outlook.
In line with this, the rising adoption of single-use bioprocessing, as it reduces the amount of carbon dioxide (CO2) compared to traditional bioprocessing, is impelling the growth of the market. Furthermore, the increasing employment of single-use bioprocessing due to the improving healthcare facilities across the globe is contributing to the growth of the market.
Key Market Segmentation
This report provides an analysis of the key trends in each sub-segment of the global single-use bioprocessing market report, along with forecasts at the global, regional and country levels from 2024-2032. The report has categorized the market based on product type, application, end-use and, end-user.Product Type Insights:
- Media Bags and Containers
- Filtration Assemblies
- Single-Use Bioreactors
- Disposable Mixers
- Others
Application Insights:
- Filtration
- Storage
- Cell Culture
- Mixing
- Purification
End-Use Insights:
- Upstream
- Fermentation
- Downstream
End-User Insights:
- Biopharmaceutical Manufacturers
- Life Science R&D
- Others
Regional Insights:
- North America
- United States
- Canada
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Peru
- Others
- Middle East and Africa
- Turkey
- Saudi Arabia
- Iran
- United Arab Emirates
- Others
Competitive Landscape
The report has also provided a comprehensive analysis of the competitive landscape in the global single-use bioprocessing market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.Some of the companies covered include Applikon Biotechnology, Boehringer Ingelheim, Cesco Bioengineering Company, Corning Inc., Danaher Corporation, Entegris, Eppendorf AG, Finesse Solutions Inc., GE Healthcare, Infors, Merck Millipore, Rentschler Biotechnologie, Sartorius Stedim Biotech, Thermo Fisher Scientific Inc., 3M Company, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
1. How big is the global single-use bioprocessing market?2. What is the expected growth rate of the global single-use bioprocessing market during 2024-2032?
3. What are the key factors driving the global single-use bioprocessing market?
4. What has been the impact of COVID-19 on the global single-use bioprocessing market?
5. What is the breakup of the global single-use bioprocessing market based on the product type?
6. What is the breakup of the global single-use bioprocessing market based on the application?
7. What is the breakup of the global single-use bioprocessing market based on the end-use?
8. What is the breakup of the global single-use bioprocessing market based on the end-user?
9. What are the key regions in the global single-use bioprocessing market?
10. Who are the key players/companies in the global single-use bioprocessing market?
Table of Contents
1 Preface3 Executive Summary12 Value Chain Analysis
2 Scope and Methodology
4 Introduction
5 Global Single-Use Bioprocessing Market
6 Market Breakup by Product Type
7 Market Breakup by Application
8 Market Breakup by End-Use
9 Market Breakup by End-User
10 Market Breakup by Region
11 SWOT Analysis
13 Porters Five Forces Analysis
14 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Applikon Biotechnology
- Boehringer Ingelheim
- Cesco Bioengineering Company
- Corning Inc.
- Danaher Corporation
- Entegris
- Eppendorf AG
- Finesse Solutions Inc.
- GE Healthcare
- Infors
- Merck Millipore
- Rentschler Biotechnologie
- Sartorius Stedim Biotech
- Thermo Fisher Scientific Inc.
- 3M Company
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 135 |
| Published | April 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 16.1 Billion |
| Forecasted Market Value ( USD | $ 64.5 Billion |
| Compound Annual Growth Rate | 16.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
